Results 311 to 320 of about 343,863 (361)

Structural brain imaging biomarkers for predicting seizure recurrence after a first unprovoked seizure

open access: yesEpilepsia Open, EarlyView.
Abstract Objectives Predicting seizure recurrence following a first unprovoked seizure (FUS) remains a significant clinical challenge, especially when routine clinical magnetic resonance imaging (MRI) and EEG do not reveal abnormalities diagnostic of epilepsy.
Suyi Ooi   +7 more
wiley   +1 more source

Characterizing electroencephalogram dynamics during sedation withdrawal: Insights into cortical recovery following status epilepticus

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Characterize electroencephalogram (EEG) dynamics during propofol withdrawal in patients with generalized convulsive status epilepticus (GCSE) and explore their association with functional outcomes. Methods We conducted a retrospective cohort study of adult patients with GCSE who received continuous EEG monitoring and propofol ...
Mathieu Dhoisne   +5 more
wiley   +1 more source

”Not always the magic bullet”—Insufficient seizure control by ketogenic dietary therapies in Glut1 Deficiency Syndrome

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Ketogenic dietary therapies (KDTs) are the treatment of choice for Glut1 Deficiency Syndrome (Glut1DS), providing dietary ketones as an alternative fuel to the brain and effectively controlling seizures. Recent evidence indicates insufficient seizure control in Glut1DS patients despite adequate KDT and ketosis.
Joerg Klepper, Eva Runkel, Lucia Kiesel
wiley   +1 more source

AES ILAE North America Symposium: Guiding Evidence-Based Epilepsy Management. [PDF]

open access: yesEpilepsy Curr
Jette N   +5 more
europepmc   +1 more source

AI for precision epilepsy: ASM response prediction needs real-world validation

open access: diamond
Areeba Naveed   +3 more
openalex   +1 more source

Practical consensus recommendations for polytherapy involving stiripentol in Dravet syndrome: A nominal group approach

open access: yesEpilepsia Open, EarlyView.
Abstract Objectives Dravet syndrome (DS) is a drug‐resistant developmental and epileptic encephalopathy, often requiring three or more antiseizure medications (ASMs). Consequently, the therapeutic landscape is highly complex, combining DS‐specific agents (stiripentol, STP; cannabidiol, CBD; fenfluramine, FFA), non‐specific ASMs, and non‐pharmacologic ...
J. Helen Cross   +4 more
wiley   +1 more source

Association Between Prophylactic Anti-Seizure Medication and Early Post-Traumatic Seizures: An International Observational Multicenter Study. [PDF]

open access: yesMedComm (2020)
Ji J   +36 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy